Early axial spondyloarthritis (axSpA), with a duration of no more than two years of axial symptoms, is associated with lower ...
New Phase 3 AFFIRM data show higher rates of clinical and endoscopic response in Crohn's disease patients treated with subcutaneous SKYRIZI versus placebo across all efficacy endpoints ...
Higher serum vitamin D levels are associated with reduced disease activity and improved functional outcomes in radiographic axial spondyloarthritis.